Amicus Therapeutics ApS is a Danish APS based in København V, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2018, the company has 1 employee and reported a gross profit of DKK 1.4m in its latest annual filing.
In its most recent annual report (2025), Amicus Therapeutics ApS reported a gross profit of DKK 1.4m, a decrease of 27% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of DKK 115.0k, and the EBITDA margin stood at 5.8%.
At the end of 2025, equity financed 10% of the balance sheet, and current assets covered short-term debt 1.1 times.
Frequently asked questions
What is the CVR number of Amicus Therapeutics ApS?
Amicus Therapeutics ApS is registered with CVR / Virk under CVR 39359340.
What is the gross profit of Amicus Therapeutics ApS?
Amicus Therapeutics ApS reported a gross profit of DKK 1.4m in 2025.
How many employees does Amicus Therapeutics ApS have?
Amicus Therapeutics ApS employs 1 people as of the latest annual report.
Who is the chairman of Amicus Therapeutics ApS?
Richard Gideon Morris chairs the board of Amicus Therapeutics ApS, in role since 2026.
Where is Amicus Therapeutics ApS headquartered?
Amicus Therapeutics ApS's registered address is Rådhuspladsen 16.
